Metformin Inhibits Porphyromonas gingivalis Lipopolysaccharide‐Influenced Inflammatory Response in Human Gingival Fibroblasts via Regulating Activating Transcription Factor‐3 Expression

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The Journal of Periodontology

• Publication date

  2017-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1902/jop.2017.170168PMID 28548885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholesterol crystals enhance TLR2- and TLR4-mediated pro-inflammatory cytokine responses of monocytes to the proatherogenic oral bacterium Porphyromonas gingivalis

  2017cited by this paper
• Mast Cells Contribute to Porphyromonas gingivalis–induced Bone Loss

  2016cited by this paper
• Healthy and Inflamed Gingival Fibroblasts Differ in Their Inflammatory Response to Porphyromonas gingivalis Lipopolysaccharide

  2016cited by this paper
• Interaction of IL1B and IL1RN polymorphisms, smoking habit, gender, and ethnicity with aggressive and chronic periodontitis susceptibility

  2016cited by this paper
• Pleiotropic Benefits of Metformin: Macrophage Targeting Its Anti-inflammatory Mechanisms

  2015cited by this paper
• Azithromycin suppresses P. gingivalis LPS-induced pro-inflammatory cytokine and chemokine production by human gingival fibroblasts in vitro

  2015cited by this paper
• Dysregulation of parkin in the substantia nigra of db/db and high-fat diet mice.

  2015cited by this paper
• Alpha-mangostin suppresses IL-6 and IL-8 expression in P. gingivalis LPS-stimulated human gingival fibroblasts

  2015cited by this paper
• Synthetic (+)-terrein suppresses interleukin-6/soluble interleukin-6 receptor induced-secretion of vascular endothelial growth factor in human gingival fibroblasts.

  2014cited by this paper
• β Mangostin suppress LPS-induced inflammatory response in RAW 264.7 macrophages in vitro and carrageenan-induced peritonitis in vivo.

  2014cited by this paper
• Metformin Suppresses Lipopolysaccharide (LPS)-induced Inflammatory Response in Murine Macrophages via Activating Transcription Factor-3 (ATF-3) Induction*

  2014cited by this paper
• IL-6 Alters Osteocyte Signaling toward Osteoblasts but Not Osteoclasts

  2014cited by this paper
• Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis

  2014cited by this paper
• Determination of the antibacterial activity of simvastatin against periodontal pathogens, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans: An in vitro study

  2014cited by this paper
• Hydrogen sulfide synergistically upregulates Porphyromonas gingivalis lipopolysaccharide-induced expression of IL-6 and IL-8 via NF-κB signalling in periodontal fibroblasts.

  2014cited by this paper
• Resistin: A Potential Biomarker for Periodontitis Influenced Diabetes Mellitus and Diabetes Induced Periodontitis

  2014cited by this paper
• Upregulation of ATF3 inhibits expression of the pro‐inflammatory cytokine IL‐6 during Neisseria gonorrhoeae infection

  2013cited by this paper
• Assessment of IL-6, IL-8 and TNF-α levels in the gingival tissue of patients with periodontitis

  2013cited by this paper
• Clinical and microbiologic effect of nonsurgical periodontal therapy on patients with chronic or aggressive periodontitis.

  2013cited by this paper
• Periodontal Disease: Linking the Primary Inflammation to Bone Loss

  2013cited by this paper
• Repositioning metformin for cancer prevention and treatment.

  2013cited by this paper
• Periodontitis among adults aged ≥30 years - United States, 2009-2010.

  2013cited by this paper
• Macrophage SR-BI regulates LPS-induced pro-inflammatory signaling in mice and isolated macrophages

  2012cited by this paper
• Understanding the benefit of metformin use in cancer treatment

  2011cited by this paper
• Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol[S]

  2010cited by this paper
• Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.

  2009cited by this paper
• Activating Transcription Factor 3 Constitutes a Negative Feedback Mechanism That Attenuates Saturated Fatty Acid/Toll-Like Receptor 4 Signaling and Macrophage Activation in Obese Adipose Tissue

  2009cited by this paper
• Lipopolysaccharide-Induced Expression of Matrix Metalloproteinases in Human Monocytes Is Suppressed by IFN-γ via Superinduction of ATF-3 and Suppression of AP-11

  2008cited by this paper
• Diabetes mellitus and periodontal disease.

  2007cited by this paper
• Negative Regulation of TLR-Signaling Pathways by Activating Transcription Factor-31

  2007cited by this paper
• Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4

  2006cited by this paper
• Metformin Inhibits Cytokine-Induced Nuclear Factor &kgr;B Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial Cells

  2006cited by this paper
• Metformin Inhibits Proinflammatory Responses and Nuclear Factor-&kgr;B in Human Vascular Wall Cells

  2005cited by this paper
• Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin.

  2004cited by this paper
• The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial.

  2004cited by this paper
• Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.

  2004cited by this paper
• Antigens of bacteria associated with periodontitis.

  2004cited by this paper
• Resolution of Inflammation: A New Paradigm for the Pathogenesis of Periodontal Diseases

  2003cited by this paper
• An alternatively spliced isoform of transcriptional repressor ATF3 and its induction by stress stimuli.

  2002cited by this paper
• Transcriptional regulation by the phosphorylation-dependent factor CREB

  2001cited by this paper
• Causation and pathogenesis of periodontal disease.

  2001cited by this paper
• Treponema socranskii, Treponema denticola, and Porphyromonas gingivalis are associated with severity of periodontal tissue destruction.

  2001cited by this paper
• Treponema socranskii, Treponema denticola, and Porphyromonas gingivalis are associated with severity of periodontal tissue destruction

  2001cited by this paper
• Invasive Shigella flexneri Activates NF-κB Through a Lipopolysaccharide-Dependent Innate Intracellular Response and Leads to IL-8 Expression in Epithelial Cells1

  2000cited by this paper
• [Centers for Disease Control and Prevention (CDC)].

  2000cited by this paper
• Mechanism by which metformin reduces glucose production in type 2 diabetes.

  2000cited by this paper
• Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids.

  2000cited by this paper
• Interleukin 1 beta, interleukin 6, beta 2-microglobulin, and transforming growth factor-alpha in gingival crevicular fluid from human periodontal disease.

  1999cited by this paper
• ATF3 and stress responses.

  1999cited by this paper
• Interleukin 1β, interleukin 6, β2-microglobulin, and transforming growth factor-α in gingival crevicular fluid from human periodontal disease

  1999cited by this paper
• Role of cytokines and inflammatory mediators in tissue destruction.

  1993cited by this paper
• Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells.

  1992cited by this paper
• IL-6 is produced by osteoblasts and induces bone resorption.

  1990cited by this paper

• Metformin as an Adjunct in Periodontal Therapy: Mechanistic Insights, Research Evidence and Current Challenges.

  2026cites this paper
• Immunopathogenesis and immunotherapy of diabetes-associated periodontitis

  2025cites this paper
• Assessing the therapeutic potential of Ganoderma lucidum spore oil in alleviating periodontal tissue damage in murine periodontitis model

  2024cites this paper
• Effects of metformin on arterial elasticity and pro-inflammatory markers in black diabetes patients

  2024cites this paper
• Improvement of periodontal parameters following intensive diabetes care and supragingival dental prophylaxis in patients with type 2 diabetes: A prospective cohort study.

  2024cites this paper
• Lipotoxicity: The missing link between diabetes and periodontitis?

  2024cites this paper
• Fusobacterium nucleatum dysregulates inflammatory cytokines and NLRP3 inflammasomes in oral cells.

  2024cites this paper
• A literature review of bioactive substances for the treatment of periodontitis: In vitro, in vivo and clinical studies

  2024cites this paper
• Evaluation of concentrated growth factors with and without metformin gel in the treatment of mandibular class II furcation defect

  2024cites this paper
• Locally-Delivered 1% Metformin Gel as an Adjunct to Scaling and Root Planning in the Treatment of Severe Chronic Periodontitis: A Randomized, Controlled Clinical Trial

  2024cites this paper
• Metformin prevents the onset and progression of intervertebral disc degeneration: New insights and potential mechanisms (Review)

  2024cites this paper
• Magnolia kobus Extract Suppresses Porphyromonas gingivalis LPS-Induced Proinflammatory Cytokine and MMP Expression in HGF-1 Cells and Regulates Osteoclastogenesis in RANKL-Stimulated RAW264.7 Cells

  2023cites this paper
• Avenanthramide-C Shows Potential to Alleviate Gingival Inflammation and Alveolar Bone Loss in Experimental Periodontitis

  2023cites this paper
• Are comorbidities associated with the cytokine/chemokine profile of persistent apical periodontitis?

  2023cites this paper
• Effects of metformin on human gingival fibroblasts: an in vitro study

  2023cites this paper
• Diabetes Medication Metformin Inhibits Osteoclast Formation and Activity in In Vitro Models for Periodontitis

  2022cites this paper
• Metformin and risk of gingival/periodontal diseases in diabetes patients: A retrospective cohort study

  2022cites this paper
• Effects of metformin on the bioactivity and osseointegration of dental implants: A systematic review

  2022cites this paper
• Metformin and sodium dichloroacetate effects on proliferation, apoptosis, and metabolic activity tested alone and in combination in a canine prostate and a bladder cancer cell line

  2021cites this paper
• Effect of Aging on Homeostasis in the Soft Tissue of the Periodontium: A Narrative Review

  2021cites this paper
• Clinical and biochemical analysis for the adjunctive effects of simvastatin and metformin in the treatment of chronic periodontitis patients

  2021cites this paper
• Metformin accelerate wound healing by Akt phosphorylation of gingival fibroblast in insulin-resistant prediabetes mice.

  2021cites this paper
• Effect of micro-osteoperforations on the gene expression profile of the periodontal ligament of orthodontically moved human teeth

  2021cites this paper
• A Clinico-radiographic comparative evaluation of 1% Metformin gel plus Platelet Rich Fibrin over Platelet Rich Fibrin alone in Treatment of Grade II Furcation Defects: A Randomized Controlled Double-blind Clinical Trial.

  2021cites this paper
• Effect of Metformin on Alveolar Bone Loss in Type 2 Diabetic Rat Model with Experimental Periodontitis

  2020cites this paper
• Porphyromonas gingivalis lipopolysaccharide and glycated serum albumin increase the production of several pro-inflammatory molecules in human gingival fibroblasts via NFκB.

  2020cites this paper
• The anti-periodontitis action of metformin via targeting NLRP3 inflammasome.

  2020cites this paper
• Hematoporphyrin monomethyl ether mediated sonodynamic antimicrobial chemotherapy on porphyromonas gingivalis in vitro.

  2020cites this paper
• Interleukin-1β is a potential therapeutic target for periodontitis: a narrative review

  2020cites this paper
• Metformin promotes osteogenic differentiation and protects against oxidative stress-induced damage in periodontal ligament stem cells via activation of the Akt/Nrf2 signaling pathway.

  2019cites this paper
• Between Innovation and Standardization, Is There Still a Room for Scientific Reports? The Rise of a Formatting Tradition in Periodontal Research

  2019cites this paper
• Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies

  2019cites this paper
• The evaluation of leukocyte-platelet rich fibrin as an anti-inflammatory autologous biological additive

  2019cites this paper
• Sonodynamic therapy as an adjunctive treatment on porphyromonas gingivalis induced periodontitis in rats with diabetes

  2019cites this paper
• LC-MS/MS method for simultaneous determination of rivaroxaban and metformin in rat plasma: application to pharmacokinetic interaction study.

  2019cites this paper
• Locally delivered metformin as adjunct to scaling and root planing in the treatment of periodontal defects: A systematic review and meta‐analysis

  2018cites this paper
• Sonodynamic therapy as an adjunctive treatment on porphyromonas gingivalis induced periodontitis in rats with diabetes

  2018cites this paper
• Prolyl hydroxylases positively regulated LPS‐induced inflammation in human gingival fibroblasts via TLR4/MyD88‐mediated AKT/NF‐κB and MAPK pathways

  2018cites this paper
• Type 1 Diabetes and Periodontal Health.

  2018cites this paper